Startseite Medizin The effect of GnRH stimulation on AMH regulation in central precocious puberty and isolated premature thelarche
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The effect of GnRH stimulation on AMH regulation in central precocious puberty and isolated premature thelarche

  • Nursel Muratoglu Sahin EMAIL logo , H. Nursun Ozcan , Aslihan Arasli Yilmaz , Senay Savas Erdeve , Semra Cetinkaya ORCID logo und Zehra Aycan
Veröffentlicht/Copyright: 4. August 2021

Abstract

Objectives

There is a complex interaction between the anti-müllerian hormone (AMH) and hypothalamic–pituitary–gonadal axis. However, the effect of gonadotropin-releasing hormone (GnRH) stimulation on AMH levels is not clearly known. In the study, we aimed to evaluate the effect of GnRH stimulation on AMH levels in central precocious puberty (CPP) and isolated premature thelarche (PT) groups.

Methods

Sixty-three girls with breast development before the age of 8 were enrolled in the study. GnRH test was performed on all subjects. Blood samples for follicle-stimulating hormone (FSH), luteinizing hormone (LH), and AMH levels were taken at basal, 40th, and 90th minute of GnRH test. Subjects were grouped as CPP and PT group.

Results

After GnRH stimulation, AMH levels increased significantly at the 40th minute and the stimulating effect of GnRH on AMH continued till the 90th minute (p: 0.0001). There was a positive correlation between basal and 90th-minute AMH levels (r: 479, p: 0.0001). The highest FSH, LH, and AMH times were significantly different after the GnRH stimulation (p: 0.001, p: 0.001, and p: 0.007). Although the CPP group had a lower basal AMH level than the PT group’s basal AMH level; AMH response to GnRH stimulation was not different (p>0.05).

Conclusions

In our study, which examined the effect of GnRH stimulation on AMH levels in early pubertal development disorders for the first time, GnRH stimulated AMH secretion rapidly, correlated with basal AMH. Basal AMH levels were lower in patients with CPP than in those with PT; however, the effect of GnRH stimulation on AMH levels was similar in both groups.


Corresponding author: Nursel Muratoglu Sahin, Associate Professor, Department of Pediatric Endocrinology, Health Sciences University, Dr Sami Ulus Obstetrics and Gynecology, Children’s Health and Disease, Health Implementation and Research Center, 06080, Ankara, Turkey, Phone: +90 312 3056515, E-mail:

Funding source: Turkey Pediatric Endocrinology and Diabetes Society

  1. Research funding: This study was supported financially by Turkey Pediatric Endocrinology and Diabetes Society

  2. Author contributions: Surgical and Medical Practices: Nursel Muratoglu Sahin, Nursun Ozcan, Aslihan Arasli Yilmaz, Senay Savas Erdeve, Semra Cetinkaya; Concept: Nursel Muratoglu Sahin; Design: Nursel Muratoglu Sahin; Data Collection or Processing: Nursel Muratoglu Sahin, Nursun Ozcan, Aslihan Arasli Yilmaz, Senay Savas Erdeve, Semra Cetinkaya; Analysis or Interpretation: Nursel Muratoglu Sahin; Literature Search: Nursel Muratoglu Sahin; Writing: Nursel Muratoglu Sahin. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The local Ethical Committee at Kecioren EAH approved the study (project no: 2012-KAEK-15/1529). All of the participants and their parents received oral and written information before signing a consent form.

References

1. Chemaitilly, W, Trivin, C, Adan, L, Gall, V, Sainte-Rose, C, Brauner, R. Central precocious puberty: clinical and laboratory features. Clin. Endocrinol. 2001;54:289–94. https://doi.org/10.1046/j.1365-2265.2001.01229.x.Suche in Google Scholar PubMed

2. Berberoglu, M. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol 2009;1:164–74.10.4274/jcrpe.v1i4.3Suche in Google Scholar PubMed PubMed Central

3. Farello, G, Altieri, C, Cutini, M, Pozzobon, G, Verrotti, A. Review of the literature on current changes in the timing of pubertal development and the incomplete forms of early puberty. Front Pediatr 2019;7:147. https://doi.org/10.3389/fped.2019.00147.Suche in Google Scholar PubMed PubMed Central

4. Cate, RL, Mattaliano, RJ, Hession, C, Tizard, R, Farber, NM, Cheung, A, et al.. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986;45:685–98. https://doi.org/10.1016/0092-8674(86)90783-x.Suche in Google Scholar PubMed

5. Durlinger, AL, Kramer, P, Karels, B, de Jong, FH, Uilenbroek, JT, Grootegoed, JA, et al.. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999;140:5789–96. https://doi.org/10.1210/endo.140.12.7204.Suche in Google Scholar PubMed

6. Durlinger, AL, Visser, JA, Themmen, AP. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002;124:601–9. https://doi.org/10.1530/rep.0.1240601.Suche in Google Scholar PubMed

7. Visser, JA, Themmen, AP. Anti-Müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;234:81–6. https://doi.org/10.1016/j.mce.2004.09.008.Suche in Google Scholar PubMed

8. Kuiri-Hänninen, T, Kallio, S, Seuri, R, Tyrväinen, E, Liakka, A, Tapanainen, J, et al.. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab 2011;96:3432–9. https://doi.org/10.1210/jc.2011-1502.Suche in Google Scholar PubMed

9. Hagen, CP, Aksglaede, L, Sorensen, K, Main, KM, Boas, M, Cleemann, L, et al.. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010;95:5003–10. https://doi.org/10.1210/jc.2010-0930.Suche in Google Scholar PubMed

10. Sahin, NM, Kinik, ST, Tekindal, MA, Bayraktar, N. AMH levels at central precocious puberty and premature thelarche: is it a parameter? J Pediatr Endocrinol Metab 2015;28:1351–6. https://doi.org/10.1515/jpem-2014-0521.Suche in Google Scholar PubMed

11. Chen, T, Wu, H, Xie, R, Wang, F, Chen, X, Sun, H, et al.. Serum AntiMüllerian hormone and inhibin B as potential markers for progressive central precocious puberty in girls. J Pediatr Adolesc Gynecol 2017;30:362–6. https://doi.org/10.1016/j.jpag.2017.01.010.Suche in Google Scholar PubMed

12. Savas-Erdeve, S, Sagsak, E, Keskin, M, Cetinkaya, S, Aycan, Z. AMH levels in girls with various pubertal problems. J Pediatr Endocrinol Metab 2017;30:333–5. https://doi.org/10.1515/jpem-2016-0217.Suche in Google Scholar PubMed

13. Josso, N, Clemente, N. Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metabol 2003;14:91–7. https://doi.org/10.1016/s1043-2760(03)00005-5.Suche in Google Scholar PubMed

14. Cimino, I, Casoni, F, Liu, X, Messina, A, Parkash, J, Jamin, SP, et al.. Novel role for antiMüllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 2016;7:10055. https://doi.org/10.1038/ncomms10055.Suche in Google Scholar PubMed PubMed Central

15. Herde, MK, Geist, K, Campbell, RE, Herbison, AE. Gonadotropin-releasing hormone neurons extend complex highly branched dendritic trees outside the blood-brain barrier. Endocrinology 2011;152:3832–41. https://doi.org/10.1210/en.2011-1228.Suche in Google Scholar PubMed

16. Resende, EA, Lara, BH, Reis, JD, Ferreira, BP, Pereira, GA, Borges, MF. Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab 2007;92:1424–9. https://doi.org/10.1210/jc.2006-1569.Suche in Google Scholar PubMed

17. Kereilwe, O, Pandey, K, Borromeo, V, Kadokawa, H. Anti‐Müllerian hormone receptor type 2 is expressed in gonadotrophs of postpu‐bertal heifers to control gonadotrophin secretion. Reprod Fertil Dev 2018;30:1192–203. https://doi.org/10.1071/rd17377.Suche in Google Scholar PubMed

18. Pellatt, L, Rice, S, Dilaver, N, Heshri, A, Galea, R, Brincat, M, et al.. Anti‐Müllerian hormone reduces follicle sensitivity to follicle‐stimulating hormone in human granulosa cells. Fertil Steril 2011;96:1246–51. https://doi.org/10.1016/j.fertnstert.2011.08.015.Suche in Google Scholar PubMed

19. Dewailly, D, Robin, G, Peigne, M, Decanter, C, Pigny, P, Catteau‐Jonard, S. Interactions between androgen, FSH, anti‐Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update 2016;22:709–24. https://doi.org/10.1093/humupd/dmw027.Suche in Google Scholar PubMed

20. Pellatt, L, Rice, S, Mason, HD. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 2010;139:825–33. https://doi.org/10.1530/rep-09-0415.Suche in Google Scholar PubMed

21. Devillers, MM, Petit, F, Cluzet, V, François, CM, Giton, F, Garrel, G, et al.. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol 2019;240:215–28. https://doi.org/10.1530/joe-18-0313.Suche in Google Scholar PubMed

22. Taieb, J, Grynberg, M, Pierre, A, Arouche, N, Massart, P, Belville, C, et al.. FSH and its second messenger cAMP stimulate the transcription of human anti-Mullerian hormone in cultured granulosa cells. Mol Endocrinol 2011;25:645–55. https://doi.org/10.1210/me.2010-0297.Suche in Google Scholar PubMed PubMed Central

23. Grynberg, M, Pierre, A, Rey, R, Leclerc, A, Arouche, N, Hesters, L, et al.. Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors. J Clin Endocrinol Metab 2012;97:E1649–57. https://doi.org/10.1210/jc.2011-3133.Suche in Google Scholar PubMed

24. Boyar, RM, Wu, RH, Roffwarg, H, Kapen, S, Weitzman, ED, Hellman, L, et al.. Human puberty: 24-hour estradiol in pubertal girls. J Clin Endocrinol Metab 1976;43:1418–21. https://doi.org/10.1210/jcem-43-6-1418.Suche in Google Scholar PubMed

25. van Helden, J, Evliyaoglu, O, Weiskirchen, R. Has GnRH a direct role in AMH regulation? Clin Endocrinol 2019;90:827–33. https://doi.org/10.1111/cen.13967.Suche in Google Scholar PubMed

26. Kandemir, N, Demirbilek, H, Alev Ozon, Z, Gonc, N, Alikasifoglu, A. GnRH stimulation test in precocious puberty: single sample is adequate for diagnosis and dose adjustment. J Clin Res Pediatr Endocrinol 2011;3:12–7. https://doi.org/10.4274/jcrpe.v3i1.03.Suche in Google Scholar PubMed PubMed Central

Received: 2021-02-12
Accepted: 2021-07-09
Published Online: 2021-08-04
Published in Print: 2021-11-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. An endocrine perspective on menstrual suppression for adolescents: achieving good suppression while optimizing bone health
  4. Original Articles
  5. Anthropometric, metabolic, and reproductive outcomes of patients with central precocious puberty treated with leuprorelin acetate 3-month depot (11.25 mg)
  6. Evaluation of the resilience of the girls with central precocious puberty treated with gonadotropin-releasing hormone analog
  7. The effect of GnRH stimulation on AMH regulation in central precocious puberty and isolated premature thelarche
  8. Association of the apoptotic marker APO1/Fas with children’s predisposing factors for metabolic syndrome and with mean platelet volume
  9. Serum adiponectin, body adiposity and metabolic parameters in obese Egyptian children with Down syndrome
  10. Urinary iodine and thyroglobulin are useful markers in infants suspected of congenital hypothyroidism based on newborn screening
  11. Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency
  12. Clinical, biochemical and genotypical characteristics in biotinidase deficiency
  13. High uric acid levels in overweight and obese children and their relationship with cardiometabolic risk factors: what is missing in this puzzle?
  14. Optimizing pediatric histrelin implantation to improve success rates in clinic without sedation
  15. Determinants of ultra-processed food consumption in Brazilian children and adolescents with type 1 diabetes mellitus: a cross-sectional study
  16. The prevalence, immune profile, and clinical characteristics of children with celiac disease and type 1 diabetes mellitus in the state of Qatar
  17. Case Reports
  18. A rare and preventable aetiology of neurodevelopmental delay and epilepsy: familial glucocorticoid deficiency
  19. Giant plurihormonal pituitary adenoma in a child – case study
  20. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report
  21. A novel synonymous homozygous variant [c.2538G>A (p.Thr846Thr)] in TRPM6 in a patient with hypomagnesemia with secondary hypocalcemia
  22. Idiopathic juvenile osteoporosis in a child: a four-year follow-up with review of literature
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0343/pdf
Button zum nach oben scrollen